company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11647000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11647000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3260000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15047000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25275000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25275000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-234000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26012000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2817000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23429000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23429000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,246000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-325000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-79000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-79000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2992000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1225000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3271000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40894000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14847000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14026000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14026000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-425000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5081000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18379000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12873000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12873000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5518000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1406000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6681000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10793000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10793000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,595000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16701000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28075000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28075000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3269000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,52906000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9506000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18594000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18594000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-418000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27965000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15811000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12572000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12572000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5338000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10649000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5378000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5378000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,161000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,805000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73518000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73518000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3332000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-55228000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4776000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26398000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26398000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-552000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19351000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11301000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8602000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8602000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-73000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7428000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7501000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7501000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1272000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9023000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4738000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,42121000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3754000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13451000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9222000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20369000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20369000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-460000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50454000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,161000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9766000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40987000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40987000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6979000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6979000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6979000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,403000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27194000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19958000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19958000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20738000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9155000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4448000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4448000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-300000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25074000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16247000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9127000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9127000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-409000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-409000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-409000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,13000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13971000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19994000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19994000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3874000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19918000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8559000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4761000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4761000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-240000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20671000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,467000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20470000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-61000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-563000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-624000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-624000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,240000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5119000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4734000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4734000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2934000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5398000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5471000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7741000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7741000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-201000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11404000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25063000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13458000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13458000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-216000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,440000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-166000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-822000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20435000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,788000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,27180000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,25910000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25910000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,837000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-13930000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12491000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25308000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25308000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-334000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46074000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14419000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31989000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31989000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-444000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-406000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-406000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,108000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6979000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,774000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-21900000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,427000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8228000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8228000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,13000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21669000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37401000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15745000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15745000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13081000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-26000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,155000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12952000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12952000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,250000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11271000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,262000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1053000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-18768000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7022000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-212000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-52139000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48150000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101578000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1077000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1077000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3626000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-12000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-296000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3934000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3934000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-143000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8245000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8245000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2219000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5774000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2016000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13816000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13816000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-972000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35112000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35611000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-531000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-531000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-115000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5654000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,404000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-661000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6026000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6026000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-215000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-297000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20885000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,525000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9538000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12236000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12236000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1985000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,657000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-600000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7814000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18008000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18008000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-275098000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,194400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5391000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-18000000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,143797000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2509000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122915000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122915000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,179000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24347000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,90000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3438000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3438000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1825000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1362000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-17008000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2675000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19934000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19934000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37540000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59125000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1527000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1527000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-369000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-9637000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9755000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9755000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-272000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28434000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,131000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,319000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15771000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15771000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1815000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1383000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9397000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1722000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20248000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20248000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28398000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54490000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26024000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26024000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-461000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-6000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-425000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-425000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5360000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2965000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63859000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63859000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1805000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1428000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56831000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20731000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24526000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24526000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35274000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51492000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16207000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16207000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-76000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,577000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-577000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-76000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-76000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,84000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-201000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8512000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,363000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13018000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13018000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,369000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1445000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,854000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10856000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21206000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21206000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13444000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21390000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21390000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,92000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,92000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,92000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,305000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3234000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,72000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,695000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1473000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2796000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7786000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1447000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1447000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8547000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,154000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17338000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8946000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8946000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-92000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,92000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-37000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-37000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,19000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7481000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,68000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,626000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1506000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3062000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2375000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7419000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7419000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1823000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5040000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3217000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3217000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-72000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4244000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3235000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,796000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1571000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4199000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3682000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8253000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8253000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-834000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6004000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5170000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5170000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,118000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-123000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-47000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,78000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3093000.0
